
Celcuity CELC
$ 99.74
-0.18%
Quarterly report 2025-Q3
added 11-13-2025
Celcuity ROE Ratio 2011-2026 | CELC
Annual ROE Ratio Celcuity
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -96.68 | -45.63 | -30.18 | -43.09 | -80.96 | -38.14 | -29.51 | -19.92 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -19.92 | -96.68 | -48.01 |
Quarterly ROE Ratio Celcuity
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -202.05 | -184.5 | -95.91 | -49.49 | -69.3 | -69.21 | -69.03 | -42.75 | -67.77 | -72.99 | -78.47 | -56.65 | -64.74 | -47.81 | -80.99 | -67.94 | -89.08 | -102.13 | -69.04 | -52.79 | -63.07 | -52.21 | -42.31 | -28.76 | -36.14 | -33.24 | -31.49 | -22.31 | -27.93 | -26.17 | -24.66 | -14.42 | -73.41 | -126.79 | -121.13 | -58.99 | -58.99 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -14.42 | -202.05 | -66.88 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M | ||
|
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M | ||
|
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | ||
|
Brainsway Ltd.
BWAY
|
-27.43 | $ 19.02 | 0.21 % | $ 99.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
-43.17 | $ 20.15 | -2.3 % | $ 217 M | ||
|
Co-Diagnostics
CODX
|
-41.08 | $ 0.17 | -6.7 % | $ 4.99 M | ||
|
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | ||
|
Danaher Corporation
DHR
|
7.87 | $ 228.92 | -0.76 % | $ 167 B | ||
|
BioNano Genomics
BNGO
|
-316.66 | $ 1.53 | 2.0 % | $ 1.94 M | ||
|
DexCom
DXCM
|
26.18 | $ 66.37 | -1.03 % | $ 25.6 B | ||
|
Castle Biosciences
CSTL
|
4.0 | $ 38.9 | -1.04 % | $ 1.08 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M | ||
|
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | ||
|
DarioHealth Corp.
DRIO
|
-102.21 | $ 11.38 | 6.36 % | $ 323 M | ||
|
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
-35.99 | $ 101.56 | -0.33 % | $ 18.8 B | ||
|
Fulgent Genetics
FLGT
|
-3.77 | $ 26.27 | -0.83 % | $ 794 M | ||
|
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
-72.81 | $ 18.84 | -1.21 % | $ 1.01 B | ||
|
IQVIA Holdings
IQV
|
22.63 | $ 225.41 | -1.0 % | $ 40.9 B | ||
|
Anixa Biosciences
ANIX
|
-62.78 | $ 3.12 | - | $ 99.5 K | ||
|
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | ||
|
Guardant Health
GH
|
312.48 | $ 102.14 | 1.53 % | $ 12.5 B | ||
|
Aspira Women's Health
AWH
|
-403.65 | - | -6.19 % | $ 10.5 M | ||
|
ENDRA Life Sciences
NDRA
|
-449.46 | $ 4.53 | -4.83 % | $ 2.43 M | ||
|
Myriad Genetics
MYGN
|
-18.16 | $ 6.15 | -0.32 % | $ 557 M | ||
|
NeoGenomics
NEO
|
-8.72 | $ 11.76 | -3.84 % | $ 1.49 B | ||
|
Illumina
ILMN
|
-51.54 | $ 131.16 | -1.2 % | $ 20.9 B | ||
|
Charles River Laboratories International
CRL
|
0.64 | $ 199.48 | -1.24 % | $ 10.2 B | ||
|
National Research Corporation
NRC
|
63.26 | $ 18.77 | 0.64 % | $ 461 M | ||
|
Quest Diagnostics Incorporated
DGX
|
12.85 | $ 173.53 | -1.12 % | $ 19.3 B | ||
|
Biodesix
BDSX
|
-205.65 | $ 6.8 | 1.19 % | $ 882 M | ||
|
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | ||
|
Laboratory Corporation of America Holdings
LH
|
9.26 | $ 250.88 | -0.87 % | $ 21 B | ||
|
ICON Public Limited Company
ICLR
|
8.31 | $ 182.22 | -0.43 % | $ 15 B | ||
|
IDEXX Laboratories
IDXX
|
55.65 | $ 676.53 | -0.85 % | $ 55.8 B | ||
|
Lantheus Holdings
LNTH
|
28.72 | $ 66.55 | -0.91 % | $ 4.61 B | ||
|
Mettler-Toledo International
MTD
|
-680.23 | $ 1 394.19 | -1.42 % | $ 29.6 B | ||
|
Precipio
PRPO
|
-40.56 | $ 22.98 | -1.84 % | $ 29.8 M | ||
|
Agilent Technologies
A
|
22.45 | $ 136.07 | -1.13 % | $ 41.4 B | ||
|
Personalis
PSNL
|
-40.05 | $ 7.96 | -0.13 % | $ 472 M | ||
|
Biomerica
BMRA
|
-121.14 | $ 2.52 | 2.86 % | $ 5.79 M | ||
|
Bioventus
BVS
|
-90.0 | $ 7.44 | -0.13 % | $ 466 M |